Teva Pharmaceutical Industries (TEVA) Shares Outstanding (2009 - 2026)

Teva Pharmaceutical Industries (TEVA) has reported Shares Outstanding (Entity) for 18 consecutive years, with $1.2 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Shares Outstanding (Entity) rose 1.58% year-over-year to $1.2 billion; the trailing twelve-month figure through Jun 2026 stood at $1.2 billion (up 1.58% YoY), and the FY2025 full-year result was $1.3 billion, up 8.33% from the prior year.
• Shares Outstanding (Entity) steadied at $1.2 billion in Q2 2026 per TEVA's latest filing, from $1.2 billion in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $1.3 billion in Q4 2025 and bottomed at $1.1 billion in Q1 2022.
• Historically, Shares Outstanding (Entity) has averaged $1.2 billion across 5 years, with a median of $1.1 billion in 2024.
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) changed 0.0% in 2022, then increased 8.33% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $1.2 billion in 2022, then changed by 0.0% to $1.2 billion in 2023, then changed by 0.0% to $1.2 billion in 2024, then increased by 8.33% to $1.3 billion in 2025, then declined by 10.36% to $1.2 billion in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $1.2 billion, $1.2 billion, and $1.3 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.